US Patent:
20210363273, Nov 25, 2021
Inventors:
- Ingelheim am Rhein, DE
Pankaj GUPTA - Scarsdale NY, US
Daniel Christopher ROWE - Ridgefield CT, US
Justin M. SCHEER - Ridgefield CT, US
Abdallah SOUABNI - Vienna, AT
Inigo TIRAPU - Vienna, AT
Joseph Ronald TUMANG - Danbury CT, US
International Classification:
C07K 16/40
C07K 16/28
A61P 35/00
Abstract:
This invention relates to binding molecules that bind specifically to CD137 and FAP and their use in medicine, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of cancer.